<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Spanko M</submitter><funding>European Structural and Investment Funds; Operational Program Research, Development and Education</funding><funding>Charles University in Prague</funding><pagination>11027</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8540903</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>22(20)</volume><pubmed_abstract>Interleukin-6 (IL-6) is a highly potent cytokine involved in multiple biological processes. It was previously reported to play a distinct role in inflammation, autoimmune and psychiatric disorders, ageing and various types of cancer. Furthermore, it is understood that IL-6 and its signaling pathways are substantial players in orchestrating the cancer microenvironment. Thus, they appear to be potential targets in anti-tumor therapy. The aim of this article is to elucidate the role of IL-6 in the tumor ecosystem and to review the possible therapeutic approaches in head and neck cancer.</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>IL-6 in the Ecosystem of Head and Neck Cancer: Possible Therapeutic Perspectives.</pubmed_title><pmcid>PMC8540903</pmcid><funding_grant_id>CZ.02.1.01/0.0/0.0/16_019/0000785</funding_grant_id><funding_grant_id>PROGRES Q28</funding_grant_id><pubmed_authors>Kodet O</pubmed_authors><pubmed_authors>Pavlicek AJ</pubmed_authors><pubmed_authors>Dvorankova B</pubmed_authors><pubmed_authors>Smetana K</pubmed_authors><pubmed_authors>Strnadova K</pubmed_authors><pubmed_authors>Spanko M</pubmed_authors><pubmed_authors>Lacina L</pubmed_authors><pubmed_authors>Valach J</pubmed_authors><pubmed_authors>Szabo P</pubmed_authors></additional><is_claimable>false</is_claimable><name>IL-6 in the Ecosystem of Head and Neck Cancer: Possible Therapeutic Perspectives.</name><description>Interleukin-6 (IL-6) is a highly potent cytokine involved in multiple biological processes. It was previously reported to play a distinct role in inflammation, autoimmune and psychiatric disorders, ageing and various types of cancer. Furthermore, it is understood that IL-6 and its signaling pathways are substantial players in orchestrating the cancer microenvironment. Thus, they appear to be potential targets in anti-tumor therapy. The aim of this article is to elucidate the role of IL-6 in the tumor ecosystem and to review the possible therapeutic approaches in head and neck cancer.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Oct</publication><modification>2026-06-19T03:17:18.914Z</modification><creation>2025-02-19T03:53:12.859Z</creation></dates><accession>S-EPMC8540903</accession><cross_references><pubmed>34681685</pubmed><doi>10.3390/ijms222011027</doi></cross_references></HashMap>